These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1397040)

  • 1. AS-5370 potently antagonizes 5-HT3 receptor-mediated responses on NG108-15 cells and on the rat vagus.
    Newberry NR; Sprosen TS; Watkins CJ; Leslie RA; Grahame-Smith DG
    Eur J Pharmacol; 1992 Aug; 219(1):135-40. PubMed ID: 1397040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRL 46470 potently antagonizes neural responses activated by 5-HT3 receptors.
    Newberry NR; Watkins CJ; Sprosen TS; Blackburn TP; Grahame-Smith DG; Leslie RA
    Neuropharmacology; 1993 Aug; 32(8):729-35. PubMed ID: 8413836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
    Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
    Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the novel 5-HT3 antagonists MDL 73147EF (dolasetron mesilate) and MDL 74156 in NG108-15 neuroblastoma x glioma cells.
    Boeijinga PH; Galvan M; Baron BM; Dudley MW; Siegel BW; Slone AL
    Eur J Pharmacol; 1992 Aug; 219(1):9-13. PubMed ID: 1397053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological consequences of ligand binding to the desensitized 5-HT3 receptor in mammalian NG108-15 cells.
    Bartrup JT; Newberry NR
    J Physiol; 1996 Feb; 490 ( Pt 3)(Pt 3):679-90. PubMed ID: 8683467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT3 receptor antagonist effects of DAT-582, (R) enantiomer of AS-5370.
    Yoshida N; Omoya H; Kato S; Ito T
    Eur J Pharmacol; 1992 Jun; 216(3):435-40. PubMed ID: 1425931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of 5-hydroxytryptamine-induced depolarizations in rat isolated vagus nerve.
    Bley KR; Eglen RM; Wong EH
    Eur J Pharmacol; 1994 Aug; 260(2-3):139-47. PubMed ID: 7988637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT3 receptors in NG108-15 neuroblastoma x glioma cells: effect of the novel agonist 1-(m-chlorophenyl)-biguanide.
    Boess FG; Sepúlveda MI; Lummis SC; Martin IL
    Neuropharmacology; 1992 Jun; 31(6):561-4. PubMed ID: 1407396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of the 5-hydroxytryptamine-induced depolarization of the ferret vagus nerve in vitro.
    Newberry NR; Watkins CJ; Reynolds DJ; Leslie RA; Grahame-Smith DG
    Eur J Pharmacol; 1992 Oct; 221(1):157-60. PubMed ID: 1459188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of antagonists to characterize the receptors mediating depolarization of the rat isolated vagus nerve by alpha, beta-methylene adenosine 5'-triphosphate.
    Trezise DJ; Kennedy I; Humphrey PP
    Br J Pharmacol; 1994 May; 112(1):282-8. PubMed ID: 8032652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-hydroxytryptamine3 (5-HT3) receptor-mediated depolarisation of the rat isolated vagus nerve: modulation by trichloroethanol and related alcohols.
    Bentley KR; Barnes NM
    Eur J Pharmacol; 1998 Jul; 354(1):25-31. PubMed ID: 9726627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors.
    Butler A; Hill JM; Ireland SJ; Jordan CC; Tyers MB
    Br J Pharmacol; 1988 Jun; 94(2):397-412. PubMed ID: 2969267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RS 23597-190: a potent and selective 5-HT4 receptor antagonist.
    Eglen RM; Bley K; Bonhaus DW; Clark RD; Hegde SS; Johnson LG; Leung E; Wong EH
    Br J Pharmacol; 1993 Sep; 110(1):119-26. PubMed ID: 8220871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Hydroxytryptamine (5-HT)-induced depolarization in isolated abdominal vagus nerves in the rat: involvement of 5-HT3 and 5-HT4 receptors.
    Nemoto M; Endo T; Minami M; Yoshioka M; Ito H; Saito H
    Res Commun Mol Pathol Pharmacol; 2001; 109(3-4):217-30. PubMed ID: 11758651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of 5-hydroxytryptamine-induced depolarization of the rat isolated vagus nerve.
    Ireland SJ; Tyers MB
    Br J Pharmacol; 1987 Jan; 90(1):229-38. PubMed ID: 3814920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of 5-HT and selective 5-HT receptor agonists and antagonists on rat dorsal vagal preganglionic neurones in vitro.
    Albert AP; Spyer KM; Brooks PA
    Br J Pharmacol; 1996 Oct; 119(3):519-26. PubMed ID: 8894172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacological characterization of 5-HT3 receptors in three isolated preparations derived from guinea-pig tissues.
    Butler A; Elswood CJ; Burridge J; Ireland SJ; Bunce KT; Kilpatrick GJ; Tyers MB
    Br J Pharmacol; 1990 Nov; 101(3):591-8. PubMed ID: 2076479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective antagonism of the GABA(A) receptor by ciprofloxacin and biphenylacetic acid.
    Green MA; Halliwell RF
    Br J Pharmacol; 1997 Oct; 122(3):584-90. PubMed ID: 9351519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The enantiomers of zacopride: an intra-species comparison of their potencies in functional and anxiolytic models.
    Bill DJ; Coleman J; Hallett I; Middlefell VC; Rhodes KF; Fletcher A
    Br J Pharmacol; 1995 Jul; 115(5):775-80. PubMed ID: 8548176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation by calcineurin of 5-HT3 receptor function in NG108-15 neuroblastoma x glioma cells.
    Boddeke HW; Meigel I; Boeijinga P; Arbuckle J; Docherty RJ
    Br J Pharmacol; 1996 Aug; 118(7):1836-40. PubMed ID: 8842451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.